GIP and choledocholithiasis: For choledocholithiasis, a protective association was again observed, with events occurring in 0.6% of GLP/GIP users versus 1.5% of non-users (RR = 2.722, 95% CI: 2.140–3.463; HR = 1.902, 95% CI: 1.483–2.439; p < 0.001).